Annual Report - 2006

Rush-Copley Cancer Care Center 2006 Annual Report

Statistical Data From 2005

  • Mission and Vision
  • Cancer Care Center: Activities and Accomplishments
  • Distribution of Cancer by Incidence Site
  • Major Site Comparison Table
  • Breast Cancer: A Special Site Study
  • Rush-Copley Oncology Committee Members
  • Glossary of Terms

Mission and Vision

To provide excellence in cancer care while meeting the needs of our community and to be recognized as the leading cancer care provider for the western suburbs

Cancer Care Center Activities And Accomplishments

Screening and Risk Assessments:

  • Skin cancer
  • Prostate cancer
  • Colorectal cancer
  • Breast cancer
  • On-line genetic risk assessment for breast cancer
  • Colorectal cancer risk assessment

Community Education:

Presented cancer education seminars and web chats on the following topics: skin cancer, breast cancer, prostate cancer, general cancer screening and prevention, colorectal cancer and smoking cessation

Community Partnerships:

  • Partnered with local business to provide free cancer education and screenings
  • 14th annual Cancer Survivors Day celebration with more than 300 in attendance
  • Regional sponsor for ACS Relay for Life (Aurora, Oswego/Montgomery, and Lower Fox Valley)
  • Look Good… Feel Better program offered in partnership with the ACS

Physician Education:

  • 20th Annual Midwest Cancer Symposium – Breast Cancer
  • Weekly tumor board conferences

Cancer Services:

  • The center invested nearly $2 million in radiation therapy technology and facility upgrades in order to continue providing patients with state-of-the-art radiation therapy services in a new comfortable setting
  • Implemented high-dose radiation therapy services (Mammosite) for the treatment of breast cancer
  • Press-Ganey patient satisfaction data ranked the Cancer Care Center's chemotherapy services among the top one percent of Chicago area cancer programs

Registry:

  • Maintained monthly Quality Review of registry data and CAP protocols
  • Accessioned 615 new cases
  • Continued hosting weekly Tumor Boards
  • Received a 100% for timely abstracting
  • Received a 100% for Case finding
  • Supported our 20th Annual Breast Cancer Symposium
  • Submitted data to the National Cancer Database, Illinois State Cancer Registry, American Cancer Society, and American College of Surgeons
  • The concordance indicator for CP3R of 85.5%, Rush-Copley's score of 92.4%, demonstrates the quality of our state-of-the-art cancer care program

Distribution Of Cancer By Incidence Site

Breast 155
Digestive System 91
Respiratory System 87
Male Genital Sysytem 54
Urinary Sysytem 32
Female Genital System 31
Thyroid 37
Lymphomas 26
Buccal Cavity/Pharynx 16
Brain 8
Brain - Benign 13
Melanoma 8
Soft Tissue 5
Leukemia 8
Unspecified 8
Myeloma 3
Sinus 1
Bones 1
   
Total 615
Analytic 569
Non-Analytic 46

Case Distribution By Primary Site: Analytic Cases Only

2005 Stage at Diagnosis

Pie graph shows the percentages for AJCC Stage of disease for all 569 analytic cases at Rush-Copley Medical Center

Major Site Comparison Table

 

Rush-Copley

Illinois*

USA*

Site

#

%

#

%

#

%

Breast (Female)

155

25

9,250

15

212,920

15

Lung

80

13

7,290

12

174,470

12

Colorectal

57

9

6,760

11

148,610

11

Prostate

49

8

8,740

15

234,460

17

Lymphomas

22

4

2,280

4

58,870

4

Corpus Uteri

18

3

1,910

3

41,200

3
Total Rush-Copley (analytic cases only): 569
Total Illinois: 60,220*
Total USA: 1,399,790*
percentages have been rounded up to nearest whole number * Based on Cancer Facts and Figures - 2006

Discussion:
Rush-Copley's Oncology Committee examined variances in breast and prostate cancer volumes, as compared to Illinois and U.S. figures. The higher number of breast cases could be explained by Rush-Copley's successful mammography screening and early detection efforts as well as an increased awareness and utilization of the Comprehensive Breast Health Program. In this community, an increasing number of prostate cancers are being diagnosed and treated in physician offices and surgi-centers, contributing to the lower number of cases reported by Rush-Copley.

Breast Cancer: A Special Site Study

Contributed by Joseph T. Meschi, M.D.

Click on the image for a copy of the
Breast Cancer Assessment
Report 2006

References:

1. Illinois Cancer Facts and Figures, 2006
2. Precis Hospital Software Registry
3. National Cancer Database, American
College of Surgeons, 1998-2002, 2003
4. Manual for Staging, Sixth Edition
5. UpToDate.com, 2006

Rush-Copley Oncology Committee Members

Due to the nature of the disease, we believe that our patients are best served by a multispecialty team of advocates. Acknowledgement is exented to the members listed.

Kaushik Patel, MD, Chair Mohammad Khan, MD, Pain Center
Salitha Reddy, MD, Vice-Chair Ramesh Kola, MD, Oncology
Syed A. Akbar, Radiology Ted Kulzcyzki, MD, Internal Medicine
Judi Bonomi, RN, MS, OCN, Director, IP Nursing Chitra S. Madhavan, MD, Oncology
Vickie Burdick, BS, RHIT, CTR, CA Registry Joseph T. Meschi, MD, Oncology
Govind Chandra, MD, Oncology Ho S. Myong, MD, Oncology
Nancy Donner, PharmD, Pharmacy Tariq Rahim, MD, Gastroenterology
Philip Duffin, MBA, Program Development Prema Ramakrishnan, CCS-P, CA Registry
Jim Gaudio, RPh, Pharmacy Leela N. Rao, MD, Oncology
William P. Gibbons, MD, Pathology Katey Royer, RN, BSN, OCN, Patient Navigator
Lynn Gringas, MT (ASCP), Laboratory Mary Shilkaitis, RN, MS, Administration
Daniel R. Hatcher, MD, Internal Medicine Richard J. Tom, MD, Ob/Gyn
David A. Hodgett, MD, Surgery Shawn O. Tyrrell, RN, MSN, Nursing Administration
John Hylton, MS, Director, Cancer Care Institute Syed Zaidi, MD, Gastroenterology
Maureen Karamol, LCSW, Case Manager/QI  

Glossary of Terms

Analytic: A case initially diagnosed and/or receiving all or part of the initial course of treatment at Copley Memorial Hospital.

Non-analytic: A case initially diagnosed and treated elsewhere, seen at Copley for subsequent treatment.

First Course of Treatment: The initial tumor-directed treatment(s) as planned by the treating physician. Generally begun within four months of diagnosis.

TNM staging: Determined at the time of first course of treatment. Requirement of the Managing Physician assists with treatment direction.

T=Tumor: The extent of the primary tumor.
N=Node: The absence or presence and extent of regional lymph nodes.
M=Metastasis: The absence or presence of distant metastasis.

NCDB: National Cancer Database
RCMC: Rush-Copley Medical Center

The annual report is a summary of the information readily available in the cancer registry. For additional information, contact the cancer registry at 630-978-6245.